BridgeBio Decides on a Bonus Issue Allocating 2 New Shares per Existing Share
[Asia Economy Reporter Geum Bo-ryeong] Bridge Biotherapeutics announced on the 8th that it has decided on a stock dividend of 2 new shares for every 1 common share.
The new shares amount to 12,774,116 common shares, and the total number of issued shares after the stock dividend will be 19,161,174 shares.
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- U.S. Treasury Secretary: "30-Day Temporary License for Russian Crude Oil Transactions"
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
The record date for the new share allocation is the 23rd of this month. The scheduled listing date is the 15th of next month.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
